Overview
Intellia is a pioneer in the development of CRISPR/Cas9 genome editing and is rapidly moving experimental therapies towards the clinic.
Our company’s unique strengths include our modular lipid nanoparticle delivery system and our determined focus on product development.
Programs & Pipeline
Each one of us together for patients
We believe our modular approach to selecting our in vivo and ex vivo programs positions us to build a full-spectrum genome editing company, with a pipeline across a range of indications. This approach enables us to generate a wealth of data that opens the potential therapeutic applications of the CRISPR/Cas9 technology across a broad range of diseases.
Full-Spectrum Blog
Meet Jen, Associate Scientist and member of Intellia’s Cultural Ambassadors. Jen serves on the Community Events team, which works to connect Intellia with local communities, from STEM volunteering to park clean-ups. Learn more: https://t.co/DhW4qbBFMy #OneIntellia #CRISPR https://t.co/HKa60Qy6WD
Today we are celebrating #NationalInternDay! A big thank you to our nine wonderful interns this summer for all the hard work and sharing your great ideas these past few months! #Oneintellia https://t.co/9oaIdxo6Qf